These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 30508852)
1. [2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: What's New with Regard to Our Older People?]. Hoffmann U; Thrun JM Dtsch Med Wochenschr; 2018 Dec; 143(24):1745-1748. PubMed ID: 30508852 [TBL] [Abstract][Full Text] [Related]
2. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
3. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. Chiang CE; Wang TD; Ueng KC; Lin TH; Yeh HI; Chen CY; Wu YJ; Tsai WC; Chao TH; Chen CH; Chu PH; Chao CL; Liu PY; Sung SH; Cheng HM; Wang KL; Li YH; Chiang FT; Chen JH; Chen WJ; Yeh SJ; Lin SJ J Chin Med Assoc; 2015 Jan; 78(1):1-47. PubMed ID: 25547819 [TBL] [Abstract][Full Text] [Related]
4. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension. Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH; J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072 [TBL] [Abstract][Full Text] [Related]
5. What's new in the ESC 2018 guidelines for arterial hypertension : The ten most important messages. Bergler-Klein J Wien Klin Wochenschr; 2019 Apr; 131(7-8):180-185. PubMed ID: 30715608 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals. Brunner HR; Arakawa K Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250 [TBL] [Abstract][Full Text] [Related]
7. Magnitude of Hypotension Based on Office and Ambulatory Blood Pressure Monitoring: Results From a Cohort of 5066 Treated Hypertensive Patients Aged 80 Years and Older. Divisón-Garrote JA; Ruilope LM; de la Sierra A; de la Cruz JJ; Vinyoles E; Gorostidi M; Escobar-Cervantes C; Velilla-Zancada SM; Segura J; Banegas JR J Am Med Dir Assoc; 2017 May; 18(5):452.e1-452.e6. PubMed ID: 28246017 [TBL] [Abstract][Full Text] [Related]
8. [Approaches to the Diagnosis and Treatment of Arterial Hypertension in the Light of European Recommendations]. Larina VN; Bart BY; Vartanian EA; Fedorova EV; Mikhailusova MP; Lunev VI Kardiologiia; 2019 Sep; 59(9):64-70. PubMed ID: 31540577 [TBL] [Abstract][Full Text] [Related]
9. [New 2018 European guidelines for the management of hypertension and comparison with the 2017 American guidelines]. Xhignesse P; Krzesinski JM Rev Med Liege; 2018 Nov; 73(11):583-591. PubMed ID: 30431248 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring. Kjeldsen SE; Aksnes TA; Ruilope LM Drugs R D; 2014 Jun; 14(2):31-43. PubMed ID: 24842751 [TBL] [Abstract][Full Text] [Related]
11. Blood pressure management in older people: balancing the risks. Naschitz JE Postgrad Med J; 2018 Jun; 94(1112):348-353. PubMed ID: 29555655 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hypertension in the elderly in 2017/2018 - what's new? Burnier M Expert Opin Pharmacother; 2019 Oct; 20(15):1869-1877. PubMed ID: 31271538 [No Abstract] [Full Text] [Related]
13. Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension. Kim BK; Rhee MY Healthcare (Basel); 2020 May; 8(2):. PubMed ID: 32375221 [TBL] [Abstract][Full Text] [Related]
14. 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension. ; Blood Press; 2013 Aug; 22(4):193-278. PubMed ID: 23777479 [No Abstract] [Full Text] [Related]
15. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)]. Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214 [TBL] [Abstract][Full Text] [Related]
16. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial. Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578 [TBL] [Abstract][Full Text] [Related]
17. [New recommendations of the ESH/ESC: smooth changes for the hypertensive patient]. Waeber B; Wuerzner G Rev Med Suisse; 2013 Sep; 9(397):1639-42, 1644. PubMed ID: 24073476 [TBL] [Abstract][Full Text] [Related]
18. [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. Williams B; Mancia G; Spiering W; Rosei EA; Azizi M; Burnier M; Clement DL; Coca A; de Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen SE; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder RE; Shlyakhto E; Tsioufis C; Aboyans V; Desormais I G Ital Cardiol (Rome); 2018 Nov; 19(11 Suppl 1):3S-73S. PubMed ID: 30520455 [No Abstract] [Full Text] [Related]
19. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial. Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R; J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636 [TBL] [Abstract][Full Text] [Related]